Drugs affecting cardiovascular system Flashcards
Division of drugs used to treat heart and blood disorders:
- Positive inotropes
- Antihypertensives and vasodilators
- Antianemic agents
- Agents influencing the blood coagulation
Positive inotropes function:
increase the strength of cardiac muscle contraction by increasing the quantity of intracellular calcium available for binding by muscle proteins.
Positive inotropes division:
I. Cardiac glycosides: digoxin
II. Phosphodiesterase inhibitors: pimobendan - congestive heart failure due to dilated cardiomyopathy and chronic degenerative mitral valvular disease in dogs
III. Catecholamines (b-adrenergic agonists): dopamine, dobutamine, epinephrine and isoproterenol
Antihypertensives and vasodilators division:
I. Angiotensin converting enzyme (ACE) inhibitors
II. Calcium channel blockers
III. beta-blockers
IV. alpha-blockers
V. Diuretics
ACE inhibitors
enalapril, benazepril, captopril, lisinopril, ramipril
- chronic congestive heart failure in dogs
- manage systemic hypertension in dogs and cats
Calcium channel blockers
amlodipine, diltiazem
- vasodilators
Beta-blockers
atenolol (propranolol, metoprolol, esmolol)
- slow heart rate and reduce myocardial O2 consumption
Alpha-blockers
prazosin (a1-adrenergic receptor blocker)
- mixed vasodilator
Diuretics
- Congestive heart failure characterized by cardiogenic pulmonary edema, pleural effusion, ascites or combination of these signs
Four classes of diuretics used to treat congestive heart failure in dogs and cats
I. loop diuretics - furosemid
II. thiazide diuretics - chlorothiazide
III. potassium-sparing diuretics - spironolactone
IV. other hypotensives - vasodilators - nitroglycerin
Antianemic agents
Treat anemia by providing components needed for red blood cells production, including hemoglobin synthesis, and by stimulating bone marrow formation of RBC
- vitamin B12, folic acid and iron (ferrum)
Agents influencing the blood coagulation:
Anticoagulants
- affect blood clotting
- interfere with clotting cascade by blocking synthesis of clotting factor VII (prothrombin, thrombin) or block the formation of fibrinogen
Name phases of the coagulation process:
- Activation of prothrombin
- The own clotting phase
- The retraction phase
Characterize first phase of the coagulation process
Activation of prothrombin:
- response to trauma on blood vessels and tissues
- releasing of thrombokinase from platelets and damaged vascular endothelium, with calcium ions catalyzes conversion of prothrombin into thrombin
Characterize the second phase of the coagulation cascade
The own clotting phase:
Thrombin converts fibrinogen into a meshwork of fibrin, forming a clot